Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Hematology | Genetic Disease | Family Medicine

Thalassemia Clinical Trials

A listing of Thalassemia medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


California

Oakland California

A clinical trial to evaluate treatments using LentiGlobin® BB305 Drug Product for patients with Beta-thalassemia Major

Colorado

Children's Hospital Colorado
Aurora Colorado 80045

A Phase 2 clinical study for patients with Nonmalignant Neoplasm

District of Columbia

Children's National Medical Center
Washington District of Columbia 20010

A Phase 2 clinical study for patients with Nonmalignant Neoplasm

Massachusetts

Children's Hospital Boston
Boston Massachusetts 02115

A Phase 2 clinical study for patients with Transfusional Iron Overload or Beta-Thalassemia

Oregon

Oregon Health and Science University
Portland Oregon 97239

A Phase 2 clinical study for patients with Nonmalignant Neoplasm

Tennessee

Monroe Carell Jr. Children's Hospital at Vanderbilt
Nashville Tennessee 37232

A Phase 2 clinical study for patients with Nonmalignant Neoplasm

Washington

Wisconsin

Children's Hospital of Wisconsin
Milwaukee Wisconsin 53201

A Phase 2 clinical study for patients with Nonmalignant Neoplasm

Australia

Novartis Investigative Site
Adelaide South Australia 5000

A clinical research study of Single arm MRI test for the treatment of Thalassemia, Non-transfusion Dependent Thalassemia, Myelodysplastic Syndromes, Myelofibrosis, Other Anemia

Novartis Investigative Site
Bedford Park South Australia 5042

A clinical research study of Single arm MRI test for the treatment of Thalassemia, Non-transfusion Dependent Thalassemia, Myelodysplastic Syndromes, Myelofibrosis, Other Anemia

Novartis Investigative Site
Camperdown New South Wales 2050

A clinical research study of Single arm MRI test for the treatment of Thalassemia, Non-transfusion Dependent Thalassemia, Myelodysplastic Syndromes, Myelofibrosis, Other Anemia

Novartis Investigative Site
East Bentleigh Victoria 3165

A clinical research study of Single arm MRI test for the treatment of Thalassemia, Non-transfusion Dependent Thalassemia, Myelodysplastic Syndromes, Myelofibrosis, Other Anemia

Novartis Investigative Site
Perth Western Australia 6000

A clinical research study of Single arm MRI test for the treatment of Thalassemia, Non-transfusion Dependent Thalassemia, Myelodysplastic Syndromes, Myelofibrosis, Other Anemia

View More »

Novartis Investigative Site
South Brisbane Queensland 4101

A clinical research study of Single arm MRI test for the treatment of Thalassemia, Non-transfusion Dependent Thalassemia, Myelodysplastic Syndromes, Myelofibrosis, Other Anemia

Novartis Investigative Site
St Leonards New South Wales 2065

A clinical research study of Single arm MRI test for the treatment of Thalassemia, Non-transfusion Dependent Thalassemia, Myelodysplastic Syndromes, Myelofibrosis, Other Anemia

Novartis Investigative Site
Woolloongabba Queensland 4102

A clinical research study of Single arm MRI test for the treatment of Thalassemia, Non-transfusion Dependent Thalassemia, Myelodysplastic Syndromes, Myelofibrosis, Other Anemia

Canada

Toronto Sick Kids Hospital
Toronto Ontario

A Phase 2 clinical study for patients with Transfusional Iron Overload or Beta-Thalassemia

China

Novartis Investigative Site
Nanning Guangxi 530021
Updated

A Phase 4 clinical study for patients with Non-transfusion Dependent Thalassemia

France

Groupe Hospitalier Henri Mondor
Créteil

Patients are needed to participate in a clinical research study evaluating SOTATERCEPT (ACE-011) for the treatment of Beta Thalassemia Major or Beta Thalassemia Intermedia

Hôpital Necker-Enfants Malades
Paris

Patients are needed to participate in a clinical research study evaluating SOTATERCEPT (ACE-011) for the treatment of Beta Thalassemia Major or Beta Thalassemia Intermedia

Hôpital Necker Enfants Malades
Paris 75015

Patients are needed to participate in a clinical research study of Blood sample to evaluate Thalassemia, Sickle Cell Disease or Myelodysplasia

Greece

Novartis Investigative Site
Athens GR-115 27
Updated

A Phase 4 clinical study for patients with Non-transfusion Dependent Thalassemia

Novartis Investigative Site
Athens GR 11527

Patients are needed to participate in a clinical research study of Deferasirox and Deferasirox + Deferoxamine to evaluate Transfusion-dependent β-thalassemia Patients or Cardiac Iron Overload

Novartis Investigative Site
Athens GR-115 27

Patients are needed to participate in a clinical research study of Deferasirox and Deferasirox + Deferoxamine to evaluate Transfusion-dependent β-thalassemia Patients or Cardiac Iron Overload

Novartis Investigative Site
Athens GR

Patients are needed to participate in a clinical research study of Deferasirox and Deferasirox + Deferoxamine to evaluate Transfusion-dependent β-thalassemia Patients or Cardiac Iron Overload

Novartis Investigative Site
Patras 26500

Patients are needed to participate in a clinical research study of Deferasirox and Deferasirox + Deferoxamine to evaluate Transfusion-dependent β-thalassemia Patients or Cardiac Iron Overload

View More »

George Papanicolaou Hospital
Thessaloniki

Patients are needed to participate in a clinical research study of Mozobil to evaluate Beta-Thalassemia

Italy

Ospedale Regionale Mecrocitemie
Cagliari 09121

A Phase 2 clinical study for patients with Transfusional Iron Overload or Beta-Thalassemia

Universita Degli Studi Di Cagliari
Cagliari 09121

Patients are needed to participate in a clinical research study evaluating SOTATERCEPT (ACE-011) for the treatment of Beta Thalassemia Major or Beta Thalassemia Intermedia

Centro della Microcitemia e delle Anemie Congenite
Genoa

A Phase 2 clinical study for patients with Transfusional Iron Overload or Beta-Thalassemia

Ente Ospedaliero Ospedali Galliera
Genova 16128

Patients are needed to participate in a clinical research study evaluating SOTATERCEPT (ACE-011) for the treatment of Beta Thalassemia Major or Beta Thalassemia Intermedia

Novartis Investigative Site
Milano MI 20122
Updated

A Phase 4 clinical study for patients with Non-transfusion Dependent Thalassemia

View More »

Fondazione IRCCS Ospedale Maggiore
Milano 20122

Patients are needed to participate in a clinical research study evaluating SOTATERCEPT (ACE-011) for the treatment of Beta Thalassemia Major or Beta Thalassemia Intermedia

Thalassemia Center San Luigi Hospital
Orbassano

A Phase 2 clinical study for patients with Transfusional Iron Overload or Beta-Thalassemia

University of Torino
Torino

Patients are needed to participate in a clinical research study of S-303 Treated Red Blood Cells (RBCs) and Conventional, untreated Red Blood Cells to evaluate Thalassemia Major

Acceleron Investigative Site
Turin

A clinical trial to evaluate treatments using ACE-536 for patients with Beta-thalassemia.

Lebanon

Novartis Investigative Site
Hazmiyeh
Updated

A Phase 4 clinical study for patients with Non-transfusion Dependent Thalassemia

Thailand

Novartis Investigative Site
Bangkok 10700
Updated

A Phase 4 clinical study for patients with Non-transfusion Dependent Thalassemia

Tunisia

Novartis Investigative Site
Tunis 1006
Updated

A Phase 4 clinical study for patients with Non-transfusion Dependent Thalassemia

Turkey

Novartis Investigative Site
Adana 01330
Updated

A Phase 4 clinical study for patients with Non-transfusion Dependent Thalassemia

Novartis Investigative Site
Istanbul 34093
Updated

A Phase 4 clinical study for patients with Non-transfusion Dependent Thalassemia

Ege University Hospital
Izmir 35100

A Phase 2 clinical study for patients with Transfusional Iron Overload or Beta-Thalassemia

Novartis Investigative Site
Izmir 35040
Updated

A Phase 4 clinical study for patients with Non-transfusion Dependent Thalassemia

United Kingdom

Novartis Investigative Site
London NW1 2PJ
Updated

A Phase 4 clinical study for patients with Non-transfusion Dependent Thalassemia

UCL Cancer Institue
London WC1E6BT

Patients are needed to participate in a clinical research study evaluating SOTATERCEPT (ACE-011) for the treatment of Beta Thalassemia Major or Beta Thalassemia Intermedia